1. American Diabetes Association (1997) Aspirin therapy in diabetes. Diabetes Care 20:1772–1773
2. Breddin HK, Krzywanek HJ, Althoff P, Schöffling K, Überla K, PARD (1986) Platelet aggregation as a risk factor in diabetes. Results of a prospective study. Klin Wochenschr 64:1042–1048
3. CAPRIE Steering Committee (1996) A randomised blinded trial of Clopidogrel versus Aspirin in Patients at Risc of Ischaemic Events (CAPRIE). Lancet 348:1329–1339
4. Chantelau E (2001) Does oral anticoagulation improve femoropedal graft patency in diabetic patients? Lessons from the Dutch BOA Study. VASA 58(Suppl) 47–49
5. Davi G, Gresele P, Violi F, Basili S, Catalano M, Giammarresi C, Volpato R, Nenci G, Ciabattoni G, Patrono C (1997) Diabetes mellitus, hypercholesterinemia and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease. Circulation 96:69–75